Scientific Discoveries | Novartis

Media Release
Oct 02, 2023
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)
Story
May 30, 2023
The future of medicine is here
Media Release
Oct 24, 2022
Novartis investigational oral monotherapy iptacopan demonstrates clinically meaningful superiority over anti-C5 treatment in Phase III APPLY-PNH study
Media Release
Dec 17, 2020
Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition
Story
Mar 02, 2021
Take a visual tour of medicines that target RNA
Story
Nov 04, 2020
Need for new heart disease medicines drives wave of potential therapies
Story
Jun 01, 2017
Minion challenges assumptions about the genome
Story
Nov 04, 2015
Giraffes have high blood pressure. Why don’t they drop dead?
Story
Apr 13, 2015
Cancer spies find drug-beating covert cells
Story
May 20, 2016
Building brain organoids to shed light on disease
Story
Feb 11, 2016
Intractable tumor cells crippled
Story
Apr 18, 2016
Factory foreman keeps liver’s line workers on task